黑色素瘤复发的临床试验
总计9405个结果
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
European Organisation for Research and Treatment...主动,不招人
-
Lytix Biopharma ASLaboratory Corporation of America; OWL主动,不招人
-
Suthee RapisuwonBristol-Myers Squibb主动,不招人
-
Novartis Pharmaceuticals完全的
-
Assistance Publique Hopitaux De Marseille完全的
-
Ludwig Institute for Cancer ResearchBristol-Myers Squibb终止
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey完全的
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia完全的
-
Aarhus University Hospital完全的
-
Prof. Dr. med. Dirk Schadendorf完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); University of Southern California; University of Connecticut; California...完全的
-
University of LouisvilleJames Graham Brown Cancer Center完全的
-
University of LouisvilleJames Graham Brown Cancer Center终止
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable Funds完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb撤销
-
Threshold Pharmaceuticals终止
-
Prof. Dr. med. Dirk Schadendorf完全的
-
University of Texas Southwestern Medical Center撤销
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer Hospital未知
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)完全的
-
Hoffmann-La Roche完全的
-
Peking University Cancer Hospital & Institute未知
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的
-
Peking University Cancer Hospital & InstituteKiang Wu Hospital未知
-
American Regent, Inc.完全的
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLC未知
-
Bristol-Myers Squibb终止恶性黑色素瘤德国, 美国, 墨西哥, 丹麦, 法国, 比利时, 英国, 西班牙
-
Hoffmann-La Roche完全的
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute完全的